RT Journal Article
SR Electronic
T1 Genome-wide studies define new genetic mechanisms of IgA vasculitis
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.10.10.24315041
DO 10.1101/2024.10.10.24315041
A1 Liu, Lili
A1 Zhu, Li
A1 Monteiro-Martins, Sara
A1 Griffin, Aaron
A1 Vlahos, Lukas J.
A1 Fujita, Masashi
A1 Berrouet, Cecilia
A1 Zanoni, Francesca
A1 Marasa, Maddalena
A1 Zhang, Jun Y.
A1 Zhou, Xu-jie
A1 Caliskan, Yasar
A1 Akchurin, Oleh
A1 Al-Akash, Samhar
A1 Jankauskiene, Augustina
A1 Bodria, Monica
A1 Chishti, Aftab
A1 Esposito, Ciro
A1 Esposito, Vittoria
A1 Claes, Donna
A1 Tesar, Vladimir
A1 Davis, Thomas K.
A1 Samsonov, Dmitry
A1 Kaminska, Dorota
A1 Hryszko, Tomasz
A1 Zaza, Gianluigi
A1 Flynn, Joseph T.
A1 Iorember, Franca
A1 Lugani, Francesca
A1 Rizk, Dana
A1 Julian, Bruce A.
A1 Hidalgo, Guillermo
A1 Kallash, Mahmoud
A1 Biancone, Luigi
A1 Amoroso, Antonio
A1 Bono, Luisa
A1 Mani, Laila-Yasmin
A1 Vogt, Bruno
A1 Lin, Fangming
A1 Sreedharan, Raji
A1 Weng, Patricia
A1 Ranch, Daniel
A1 Xiao, Nianzhou
A1 Quiroga, Alejandro
A1 Matar, Raed Bou
A1 Rheault, Michelle N.
A1 Wenderfer, Scott
A1 Selewski, Dave
A1 Lundberg, Sigrid
A1 Silva, Cynthia
A1 Mason, Sherene
A1 Mahan, John D.
A1 Vasylyeva, Tetyana L.
A1 Mucha, Krzysztof
A1 Foroncewicz, Bartosz
A1 Pączek, Leszek
A1 Florczak, Michał
A1 Olszewska, Małgorzata
A1 Gradzińska, Agnieszka
A1 Szczepańska, Maria
A1 Machura, Edyta
A1 Badeński, Andrzej
A1 Krakowczyk, Helena
A1 Sikora, Przemysław
A1 Kwella, Norbert
A1 Miklaszewska, Monika
A1 Drożdż, Dorota
A1 Zaniew, Marcin
A1 Pawlaczyk, Krzysztof
A1 Siniewicz-Luzeńczyk, Katarzyna
A1 Bomback, Andrew S.
A1 Appel, Gerald B.
A1 Izzi, Claudia
A1 Scolari, Francesco
A1 Materna-Kiryluk, Anna
A1 Mizerska-Wasiak, Malgorzata
A1 Berthelot, Laureline
A1 Pillebout, Evangeline
A1 Monteiro, Renato C.
A1 Novak, Jan
A1 Green, Todd Jason
A1 Smoyer, William E.
A1 Hastings, M. Colleen
A1 Wyatt, Robert J.
A1 Nelson, Raoul
A1 Martin, Javier
A1 González-Gay, Miguel A.
A1 De Jager, Philip L.
A1 Köttgen, Anna
A1 Califano, Andrea
A1 Gharavi, Ali G.
A1 Zhang, Hong
A1 Kiryluk, Krzysztof
YR 2024
UL http://medrxiv.org/content/early/2024/10/11/2024.10.10.24315041.abstract
AB IgA vasculitis (IgAV) is a pediatric disease with skin and systemic manifestations. Here, we conducted genome, transcriptome, and proteome-wide association studies in 2,170 IgAV cases and 5,928 controls, generated IgAV-specific maps of gene expression and splicing from blood of 255 pediatric cases, and reconstructed myeloid-specific regulatory networks to define disease master regulators modulated by the newly identified disease driver genes. We observed significant association at the HLA-DRB1 (OR=1.55, P=1.1×10−25) and fine-mapped specific amino-acid risk substitutions in DRβ1. We discovered two novel non-HLA loci: FCAR (OR=1.51, P=1.0×10−20) encoding a myeloid IgA receptor FcαR, and INPP5D (OR=1.34, P=2.2×10−09) encoding a known inhibitor of FcαR signaling. The FCAR risk locus co-localized with a cis-eQTL increasing FCAR expression; the risk alleles disrupted a PRDM1 binding motif within a myeloid enhancer of FCAR. Another risk locus was associated with a higher genetically predicted levels of plasma IL6R. The IL6R risk haplotype carried a missense variant contributing to accelerated cleavage of IL6R into a soluble form. Using systems biology approaches, we prioritized IgAV master regulators co-modulated by FCAR, INPP5D and IL6R in myeloid cells. We additionally identified 21 shared loci in a cross-phenotype analysis of IgAV with IgA nephropathy, including novel loci PAID4, WLS, and ANKRD55.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by the NIH grants 1K01DK137031 (LL), 2R01DK105124 (KK, JN), 1RC2DK116690 (KK). JN and TJG are supported in part by NIH grants AI149431, DK078244, and DK082753. ATG was supported by the Ruth L. Kirschstein National Research Service Awards 5T32GM007367-43 and F30CA257765. The work of AK was supported by German Research Foundation (DFG) Project ID 431984000 (SFB 1453) and Project ID 390939984 (EXC-2189, CIBSS). The work of SMM was supported by the EQUIP Program for Medical Scientists, Faculty of Medicine, University of Freiburg. AC was supported by the NCI Outstanding Investigator award R35CA197745. The GIGA-kids Study was additionally supported by the Pediatric Nephrology Research Consortium (PNRC) and a gift from the IgA Nephropathy Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study participants provided informed consent to participate in genetic studies and the Institutional Review Board of Columbia University as well as local ethics review committees for each of the individual recruitment sites approved our study protocol.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesThe genetic and transcriptomic data generated by this study is being deposited in dbGAP; the accession number will be provided before publication.